SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001633070-23-000016
Filing Date
2023-08-03
Accepted
2023-08-03 16:12:16
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q axla-20230630.htm   iXBRL 10-Q 756114
2 EX-31.1 exhibit311q22023.htm EX-31.1 10466
3 EX-31.2 exhibit312q22023.htm EX-31.2 10298
4 EX-32.1 exhibit321q22023.htm EX-32.1 6966
  Complete submission text file 0001633070-23-000016.txt   4098677

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axla-20230630.xsd EX-101.SCH 24082
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axla-20230630_cal.xml EX-101.CAL 43298
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axla-20230630_def.xml EX-101.DEF 91317
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axla-20230630_lab.xml EX-101.LAB 399175
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axla-20230630_pre.xml EX-101.PRE 247875
50 EXTRACTED XBRL INSTANCE DOCUMENT axla-20230630_htm.xml XML 504510
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38901 | Film No.: 231140113
SIC: 2836 Biological Products, (No Diagnostic Substances)